The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
It is always encouraging to see that other TTOs are encountering the same problems that we do!
Aurore De Boom
Université Libré de Bruxelle, Belgium
The best opportunity to learn and discuss common issues and interests directly with peers.
Ian Nicoud
LURIS, Netherlands
The software course has provided invaluable information as our TTO expands to take on software cases.
Tom Withnell
University of Vienna, Austria
Most experienced technology transfer crew in the Europe.
Krzysztof Maternicki
Jan Dlugosz University, Poland
Great atmosphere to learn and to share experiences.
Maria Ruiz Novales
Interface-Enterprises - University of Liege, Belgium
Join our newsletter and get the latest news